Genmark, ViroNovative Settle Patent-infringement Dispute | GenomeWeb

NEW YORK (GenomeWeb) – A years-long legal battle between Genmark Diagnostics and ViroNovative has been settled, putting an end to a dispute over whether Genmark's eSensor Respiratory Virus Panel infringed ViroNovative's intellectual property related to the detection of human metapneumovirus.

Rob Posthumus, ViroNovative's legal counsel, told GenomeWeb that the companies have signed an agreement, under which ViroNovative licensed to Genmark the IP at the center of the row. They also have agreed to dismiss lawsuits filed against each other. He declined further comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.